Examining Benefits of HAART Continuation in Postpartum Women
Condition: HIV InfectionIntervention: Drug: Highly active antiretroviral therapy (HAART)Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Active, not recruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Child Development | Children | Clinical Trials | Health | Highly Active Antiretroviral Therapy | HIV AIDS | Infectious Diseases | Pediatrics | Research | Women